Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 93 (RPL21P93)

Target: RPL21P93
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L21 pseudogene 93 (RPL21P93) is a processed pseudogene related to the ribosomal protein L21 gene (RPL21). Pseudogenes such as RPL21P93 are typically unable to encode a functional protein due to disabling mutations. Pseudogenes like this are often the result of retrotransposition or genomic duplication events followed by mutations, and they are not considered functional therapeutic targets[2][3][5]. The functional RPL21 protein is a component of the 60S ribosomal subunit, but RPL21P93 itself has no known biological role or disease association, does not interact with drugs, and is not used as a biomarker or therapeutic target[2][5].

Other names: RPL21_36_1027RPL21P93

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 93 (RPL21P93).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 93 (RPL21P93).

Explore the full profile